Diasorin Stock Price, News & Analysis (OTCMKTS:DSRLF)

$90.94 0.00 (0.00 %)
(As of 12/11/2017 04:00 PM ET)
Previous Close$90.94
Today's RangeN/A
52-Week Range$54.86 - $93.25
Average Volume38 shs
Market Capitalization$5.09 billion
P/E RatioN/A
Dividend YieldN/A

About Diasorin (OTCMKTS:DSRLF)

DiaSorin S.p.A. engages in the development, production, and commercialization of diagnostic tests that are designed for hospital and private testing laboratories for use in various clinical areas in the market of immunodiagnostics and molecular diagnostics. The company offers immunodiagnostics products in the areas of infectious diseases; bone and mineral metabolism; endocrinology, including diabetes, thyroid function, fertility, growth, adrenal function, and gastroenterology; hypertension; oncology; gastrointestinal infections; autoimmunity; and cardiac and brain damages. Its immunodiagnostics systems include LIAISON XL, an automated chemiluminescence analyzer; LIAISON analyzer; ETI Max 3000, an automated microtiter plate analyzer; EVOlyzer 2-150/8 with disposable tips; and ELISA washers and readers. The company also offers molecular diagnostic products for oncology, hematology, and infectious diseases; systems, including LIAISON IXT and BULLET Pro to extract the nucleic acid from various biological samples; and LIAISON IAM to diagnose and monitor various infectious diseases and onco-hematology parameters. It sells its products directly, as well as through an international network of independent distributors in Europe, Africa, Central America, South America, the Asia Pacific, and North America. DiaSorin S.p.A. was founded in 1968 and is headquartered in Saluggia, Italy.

Receive DSRLF News and Ratings via Email

Sign-up to receive the latest news and ratings for DSRLF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E Ratio28.60
P/E Growth2.6

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding Shares55,950,000

Diasorin (OTCMKTS:DSRLF) Frequently Asked Questions

What is Diasorin's stock symbol?

Diasorin trades on the OTCMKTS under the ticker symbol "DSRLF."

Who are some of Diasorin's key competitors?

How do I buy Diasorin stock?

Shares of Diasorin can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Diasorin's stock price today?

One share of Diasorin stock can currently be purchased for approximately $90.94.

How big of a company is Diasorin?

Diasorin has a market capitalization of $5.09 billion.

How can I contact Diasorin?

Diasorin's mailing address is Via Crescentino, Saluggia L6, 13040. The company can be reached via phone at 390-161-4871 or via email at [email protected]

MarketBeat Community Rating for Diasorin (DSRLF)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  3 (Vote Outperform)
Underperform Votes:  5 (Vote Underperform)
Total Votes:  8
MarketBeat's community ratings are surveys of what our community members think about Diasorin and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Diasorin (OTCMKTS:DSRLF) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Earnings History for Diasorin (OTCMKTS:DSRLF)

No earnings announcements for this company have been tracked by MarketBeat.com


Diasorin (OTCMKTS:DSRLF) Earnings Estimates

Current Year EPS Consensus Estimate: $3.18 EPS
Next Year EPS Consensus Estimate: $3.58 EPS


Dividend History for Diasorin (OTCMKTS:DSRLF)

No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Diasorin (OTCMKTS DSRLF)

No insider trades for this company have been tracked by MarketBeat.com


Diasorin (OTCMKTS DSRLF) News Headlines

Diasorin (DSRLF) Lowered to Hold at Zacks Investment ResearchDiasorin (DSRLF) Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - December 5 at 7:22 PM

SEC Filings

Diasorin (OTCMKTS:DSRLF) SEC Filings

DateFilerForm TypeView

Social Media


Financials are not available for this stock.


Diasorin (OTCMKTS DSRLF) Stock Chart for Monday, December, 11, 2017

Loading chart…

This page was last updated on 12/11/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.